サマリー

Peripheral neuropathy is a syndrome caused by sensory loss, muscle weakness and atrophy, decreased tendon reflexes, and vasomotor symptoms, alone or in any combination. Of all the options for the treatment of peripheral neuritis, analgesics and local anesthetics are the first line of treatment to relieve the inflammation of peripheral nerves.

Market Analysis and Insights: Global Peripheral Neuritis Treatment Market
The global Peripheral Neuritis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Peripheral Neuritis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Peripheral Neuritis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Peripheral Neuritis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Peripheral Neuritis Treatment market.

Global Peripheral Neuritis Treatment Scope and Market Size
Peripheral Neuritis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Peripheral Neuritis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Diabetic Peripheral Neuropathy (DPN)
Chemotherapy-induced Peripheral Neuropathy (CIPN)
Idiopathic Peripheral Neuropathy (IPN)
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Depomed
Novartis
Biogen
GlaxoSmithKline
Sanofi
Eli Lilly and Company
Bristol-Myers Squibb
Baxter Healthcare
Johnson & Johnson
Teva Pharmaceuticals

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Neuritis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diabetic Peripheral Neuropathy (DPN)
1.2.3 Chemotherapy-induced Peripheral Neuropathy (CIPN)
1.2.4 Idiopathic Peripheral Neuropathy (IPN)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Peripheral Neuritis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Peripheral Neuritis Treatment Market Perspective (2016-2027)
2.2 Peripheral Neuritis Treatment Growth Trends by Regions
2.2.1 Peripheral Neuritis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Peripheral Neuritis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Peripheral Neuritis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Peripheral Neuritis Treatment Industry Dynamic
2.3.1 Peripheral Neuritis Treatment Market Trends
2.3.2 Peripheral Neuritis Treatment Market Drivers
2.3.3 Peripheral Neuritis Treatment Market Challenges
2.3.4 Peripheral Neuritis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Peripheral Neuritis Treatment Players by Revenue
3.1.1 Global Top Peripheral Neuritis Treatment Players by Revenue (2016-2021)
3.1.2 Global Peripheral Neuritis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Peripheral Neuritis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Peripheral Neuritis Treatment Revenue
3.4 Global Peripheral Neuritis Treatment Market Concentration Ratio
3.4.1 Global Peripheral Neuritis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Neuritis Treatment Revenue in 2020
3.5 Peripheral Neuritis Treatment Key Players Head office and Area Served
3.6 Key Players Peripheral Neuritis Treatment Product Solution and Service
3.7 Date of Enter into Peripheral Neuritis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Peripheral Neuritis Treatment Breakdown Data by Type
4.1 Global Peripheral Neuritis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Peripheral Neuritis Treatment Forecasted Market Size by Type (2022-2027)

5 Peripheral Neuritis Treatment Breakdown Data by Application
5.1 Global Peripheral Neuritis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Peripheral Neuritis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Peripheral Neuritis Treatment Market Size (2016-2027)
6.2 North America Peripheral Neuritis Treatment Market Size by Type
6.2.1 North America Peripheral Neuritis Treatment Market Size by Type (2016-2021)
6.2.2 North America Peripheral Neuritis Treatment Market Size by Type (2022-2027)
6.2.3 North America Peripheral Neuritis Treatment Market Size by Type (2016-2027)
6.3 North America Peripheral Neuritis Treatment Market Size by Application
6.3.1 North America Peripheral Neuritis Treatment Market Size by Application (2016-2021)
6.3.2 North America Peripheral Neuritis Treatment Market Size by Application (2022-2027)
6.3.3 North America Peripheral Neuritis Treatment Market Size by Application (2016-2027)
6.4 North America Peripheral Neuritis Treatment Market Size by Country
6.4.1 North America Peripheral Neuritis Treatment Market Size by Country (2016-2021)
6.4.2 North America Peripheral Neuritis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Peripheral Neuritis Treatment Market Size (2016-2027)
7.2 Europe Peripheral Neuritis Treatment Market Size by Type
7.2.1 Europe Peripheral Neuritis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Peripheral Neuritis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Peripheral Neuritis Treatment Market Size by Type (2016-2027)
7.3 Europe Peripheral Neuritis Treatment Market Size by Application
7.3.1 Europe Peripheral Neuritis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Peripheral Neuritis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Peripheral Neuritis Treatment Market Size by Application (2016-2027)
7.4 Europe Peripheral Neuritis Treatment Market Size by Country
7.4.1 Europe Peripheral Neuritis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Peripheral Neuritis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Peripheral Neuritis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Peripheral Neuritis Treatment Market Size by Type
8.2.1 Asia-Pacific Peripheral Neuritis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Peripheral Neuritis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Peripheral Neuritis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Peripheral Neuritis Treatment Market Size by Application
8.3.1 Asia-Pacific Peripheral Neuritis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Peripheral Neuritis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Peripheral Neuritis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Peripheral Neuritis Treatment Market Size by Region
8.4.1 Asia-Pacific Peripheral Neuritis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Peripheral Neuritis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Peripheral Neuritis Treatment Market Size (2016-2027)
9.2 Latin America Peripheral Neuritis Treatment Market Size by Type
9.2.1 Latin America Peripheral Neuritis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Peripheral Neuritis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Peripheral Neuritis Treatment Market Size by Type (2016-2027)
9.3 Latin America Peripheral Neuritis Treatment Market Size by Application
9.3.1 Latin America Peripheral Neuritis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Peripheral Neuritis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Peripheral Neuritis Treatment Market Size by Application (2016-2027)
9.4 Latin America Peripheral Neuritis Treatment Market Size by Country
9.4.1 Latin America Peripheral Neuritis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Peripheral Neuritis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Peripheral Neuritis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Peripheral Neuritis Treatment Market Size by Type
10.2.1 Middle East & Africa Peripheral Neuritis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Peripheral Neuritis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Peripheral Neuritis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Peripheral Neuritis Treatment Market Size by Application
10.3.1 Middle East & Africa Peripheral Neuritis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Peripheral Neuritis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Peripheral Neuritis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Peripheral Neuritis Treatment Market Size by Country
10.4.1 Middle East & Africa Peripheral Neuritis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Peripheral Neuritis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Peripheral Neuritis Treatment Introduction
11.1.4 Pfizer Revenue in Peripheral Neuritis Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Depomed
11.2.1 Depomed Company Details
11.2.2 Depomed Business Overview
11.2.3 Depomed Peripheral Neuritis Treatment Introduction
11.2.4 Depomed Revenue in Peripheral Neuritis Treatment Business (2016-2021)
11.2.5 Depomed Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Peripheral Neuritis Treatment Introduction
11.3.4 Novartis Revenue in Peripheral Neuritis Treatment Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Biogen
11.4.1 Biogen Company Details
11.4.2 Biogen Business Overview
11.4.3 Biogen Peripheral Neuritis Treatment Introduction
11.4.4 Biogen Revenue in Peripheral Neuritis Treatment Business (2016-2021)
11.4.5 Biogen Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Peripheral Neuritis Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Peripheral Neuritis Treatment Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Peripheral Neuritis Treatment Introduction
11.6.4 Sanofi Revenue in Peripheral Neuritis Treatment Business (2016-2021)
11.6.5 Sanofi Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Details
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company Peripheral Neuritis Treatment Introduction
11.7.4 Eli Lilly and Company Revenue in Peripheral Neuritis Treatment Business (2016-2021)
11.7.5 Eli Lilly and Company Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Peripheral Neuritis Treatment Introduction
11.8.4 Bristol-Myers Squibb Revenue in Peripheral Neuritis Treatment Business (2016-2021)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Baxter Healthcare
11.9.1 Baxter Healthcare Company Details
11.9.2 Baxter Healthcare Business Overview
11.9.3 Baxter Healthcare Peripheral Neuritis Treatment Introduction
11.9.4 Baxter Healthcare Revenue in Peripheral Neuritis Treatment Business (2016-2021)
11.9.5 Baxter Healthcare Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Peripheral Neuritis Treatment Introduction
11.10.4 Johnson & Johnson Revenue in Peripheral Neuritis Treatment Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development
11.11 Teva Pharmaceuticals
11.11.1 Teva Pharmaceuticals Company Details
11.11.2 Teva Pharmaceuticals Business Overview
11.11.3 Teva Pharmaceuticals Peripheral Neuritis Treatment Introduction
11.11.4 Teva Pharmaceuticals Revenue in Peripheral Neuritis Treatment Business (2016-2021)
11.11.5 Teva Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details